Aspen Pharmacare Holdings マネジメント
マネジメント 基準チェック /44
Aspen Pharmacare Holdingsの CEO はStephen Saadで、 Jan2000年に任命され、 の在任期間は 24.83年です。 の年間総報酬はZAR 27.30Mで、 35.2%給与と64.8%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の11.82%を直接所有しており、その価値はZAR 8.94B 。経営陣と取締役会の平均在任期間はそれぞれ7.7年と5.6年です。
主要情報
Stephen Saad
最高経営責任者
R27.3m
報酬総額
| CEO給与比率 | 35.2% |
| CEO在任期間 | 24.8yrs |
| CEOの所有権 | 11.8% |
| 経営陣の平均在職期間 | 7.7yrs |
| 取締役会の平均在任期間 | 5.6yrs |
経営陣の近況
Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation Is Looking A Bit Stretched At The Moment
Dec 01
Shareholders Will Probably Not Have Any Issues With Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation
Dec 02Recent updates
Aspen Pharmacare Holdings Limited (JSE:APN) Not Lagging Market On Growth Or Pricing
Nov 09Aspen Pharmacare Holdings' (JSE:APN) Conservative Accounting Might Explain Soft Earnings
Oct 10Here's Why Aspen Pharmacare Holdings (JSE:APN) Has A Meaningful Debt Burden
Oct 01Aspen Pharmacare Holdings (JSE:APN) Has Announced That It Will Be Increasing Its Dividend To ZAR3.59
Sep 10We Think Aspen Pharmacare Holdings (JSE:APN) Can Stay On Top Of Its Debt
May 08Aspen Pharmacare Holdings Limited's (JSE:APN) P/E Still Appears To Be Reasonable
Mar 05Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet
Dec 22Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation Is Looking A Bit Stretched At The Moment
Dec 01Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet
Mar 31With EPS Growth And More, Aspen Pharmacare Holdings (JSE:APN) Makes An Interesting Case
Jan 11These 4 Measures Indicate That Aspen Pharmacare Holdings (JSE:APN) Is Using Debt Reasonably Well
Oct 22We Ran A Stock Scan For Earnings Growth And Aspen Pharmacare Holdings (JSE:APN) Passed With Ease
Oct 06Aspen Pharmacare Holdings' (JSE:APN) Upcoming Dividend Will Be Larger Than Last Year's
Sep 21Aspen Pharmacare Holdings Limited (JSE:APN) Analysts Just Cut Their EPS Forecasts Substantially
Sep 08Aspen Pharmacare Holdings (JSE:APN) Is Increasing Its Dividend To ZAR3.26
Sep 07Here's Why We Think Aspen Pharmacare Holdings (JSE:APN) Might Deserve Your Attention Today
Jun 15Aspen Pharmacare Holdings (JSE:APN) Seems To Use Debt Quite Sensibly
Apr 02With EPS Growth And More, Aspen Pharmacare Holdings (JSE:APN) Is Interesting
Mar 16An Intrinsic Calculation For Aspen Pharmacare Holdings Limited (JSE:APN) Suggests It's 33% Undervalued
Mar 02Is Aspen Pharmacare Holdings (JSE:APN) A Risky Investment?
Dec 23Shareholders Will Probably Not Have Any Issues With Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation
Dec 02We Think Aspen Pharmacare Holdings' (JSE:APN) Robust Earnings Are Conservative
Oct 11After Leaping 42% Aspen Pharmacare Holdings Limited (JSE:APN) Shares Are Not Flying Under The Radar
Sep 30Aspen Pharmacare Holdings Limited (JSE:APN) Looks Just Right With A 42% Price Jump
Sep 30CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jun 30 2024 | R27m | R10m | R4b |
| Mar 31 2024 | n/a | n/a | R5b |
| Dec 31 2023 | n/a | n/a | R5b |
| Sep 30 2023 | n/a | n/a | R5b |
| Jun 30 2023 | R24m | R9m | R5b |
| Mar 31 2023 | n/a | n/a | R6b |
| Dec 31 2022 | n/a | n/a | R6b |
| Sep 30 2022 | n/a | n/a | R6b |
| Jun 30 2022 | R23m | R9m | R6b |
| Mar 31 2022 | n/a | n/a | R6b |
| Dec 31 2021 | n/a | n/a | R6b |
| Sep 30 2021 | n/a | n/a | R5b |
| Jun 30 2021 | R24m | R8m | R5b |
| Mar 31 2021 | n/a | n/a | R4b |
| Dec 31 2020 | n/a | n/a | R4b |
| Sep 30 2020 | n/a | n/a | R4b |
| Jun 30 2020 | R23m | R8m | R3b |
| Mar 31 2020 | n/a | n/a | R3b |
| Dec 31 2019 | n/a | n/a | R870m |
| Sep 30 2019 | n/a | n/a | R1b |
| Jun 30 2019 | R14m | R8m | R2b |
| Mar 31 2019 | n/a | n/a | R3b |
| Dec 31 2018 | n/a | n/a | R5b |
| Sep 30 2018 | n/a | n/a | R5b |
| Jun 30 2018 | R17m | R7m | R6b |
報酬と市場: Stephenの 総報酬 ($USD 1.51M ) は、 ZA市場 ($USD 1.51M ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Stephenの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
Stephen Saad (60 yo)
24.8yrs
在職期間
R27,303,000
報酬
Mr. Stephen Bradley Saad, BCom, CA(SA), serves as the Group Chief Executive Officer of Aspen Pharmacare Canada Inc. Mr. Stephen has been the Group Chief Executive Officer of Aspen Pharmacare Holdings Limit...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Group CEO & Executive Director | 24.8yrs | R27.30m | 11.82% ZAR 8.9b | |
| Group CFO & Executive Director | 25.8yrs | R16.66m | データなし | |
| Group Chief Operations Officer & Responsible Pharmacist | 11yrs | R17.18m | データなし | |
| Group Chief Advisor | 2.8yrs | R11.14m | 4.32% ZAR 3.3b | |
| Group Chief Corporate Services Officer & Executive Director | less than a year | R13.79m | データなし | |
| Group Chief Strategic Development Officer | 4.5yrs | R12.81m | データなし | |
| Investor Relations Manager | no data | データなし | データなし | |
| Group Company Secretary & Chief of Staff | less than a year | データなし | データなし | |
| Regional Chief Executive Officer of Asia Pacific | 10.8yrs | データなし | データなし | |
| Chief Executive Officer of Aspen Global Incorporated | 7.7yrs | データなし | データなし | |
| Corporate Affairs & Investor Relations Executive | no data | データなし | データなし |
7.7yrs
平均在職期間
54.5yo
平均年齢
経験豊富な経営陣: APNの経営陣は経験豊富で経験豊富です（平均在職期間は7.7年）。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Group CEO & Executive Director | 25.8yrs | R27.30m | 11.82% ZAR 8.9b | |
| Group CFO & Executive Director | 2.8yrs | R16.66m | データなし | |
| Group Chief Corporate Services Officer & Executive Director | less than a year | R13.79m | データなし | |
| Lead Independent Non-Executive Director | 5.6yrs | R1.27m | データなし | |
| Non-Executive Director | 25.8yrs | R551.00k | データなし | |
| Independent Non-Executive Chairman | 12.6yrs | R1.49m | データなし | |
| Independent Non-Executive Director | 2.9yrs | R1.08m | データなし | |
| Non-Executive Director | 9.8yrs | R427.00k | データなし | |
| Independent Non-Executive Director | 6.3yrs | R1.14m | データなし | |
| Independent Non-Executive Director | less than a year | R183.00k | データなし | |
| Independent Non-Executive Director | 5.6yrs | R432.00k | データなし |
5.6yrs
平均在職期間
57yo
平均年齢
経験豊富なボード: APNの 取締役会 は 経験豊富 であると考えられます ( 5.6年の平均在任期間)。